Prescription drug · ANDA
Tolterodine Tartrate (Tolterodine) NDC 60687-330
Tolterodine tartrate 4 mg/1 · Capsule, Extended release · Oral · American Health Packaging
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 60687-330-21 | 6068703302160687033021 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-330-21) / 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (60687-330-11)Marketed from Aug 14, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Tolterodine Tartrate
- Generic name (nonproprietary)
- tolterodine
- Active ingredients
- Tolterodine tartrate — 4 mg/1
- Dosage form
- Capsule, Extended release
- Route
- Oral
- Labeler
- American Health PackagingNDC labeler code 60687
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203016
- Marketing start
- Listing expires
- Other FDA classes
- Cholinergic Muscarinic Antagonists (Mechanism)
- Identifiers
- Product ID 60687-330_5c8c8fcd-3656-3376-e063-6394a90a1c61SPL ID 5c8c8fcd-3656-3376-e063-6394a90a1c61
- Pharmacologic class
- Cholinergic Muscarinic Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N460687033021followed by a unit qualifier and the quantityPackage 60687-0330-21. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 60687-330
- What is NDC 60687-330?
- 60687-330 is the product NDC for Tolterodine Tartrate (tolterodine), Tolterodine tartrate 4 mg/1 capsule, extended release, listed with the FDA by American Health Packaging. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Tolterodine Tartrate (Tolterodine).
- What is the active ingredient?
- Tolterodine tartrate.
- Who is the labeler?
- American Health Packaging, NDC labeler code 60687. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Tolterodine Tartrate?
- 31 other product NDCs are listed under this name. See all Tolterodine Tartrate NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Tolterodine Tartrate products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Tolterodine Tartrate | Tolterodine tartrate 2 mg/1 | Capsule, Extended releaseOral | Major Pharmaceuticals | 0904-7574 | 00904-7574-04 |
| Tolterodine Tartrate | Tolterodine tartrate 4 mg/1 | Capsule, Extended releaseOral | Major Pharmaceuticals | 0904-7575 | 00904-7575-04 |
| Tolterodine tartrate | Tolterodine tartrate 4 mg/1 | Capsule, Extended releaseOral | Unichem Pharmaceuticals (USA), Inc. | 29300-307 | 29300-0307-0529300-0307-1329300-0307-19 |
| Tolterodine tartrate | Tolterodine tartrate 2 mg/1 | Capsule, Extended releaseOral | Unichem Pharmaceuticals (USA), Inc. | 29300-306 | 29300-0306-0529300-0306-1329300-0306-19 |
| Tolterodine Tartrate | Tolterodine tartrate 2 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-806 | 31722-0806-0131722-0806-0231722-0806-05+1 more |
| Tolterodine Tartrate | Tolterodine tartrate 1 mg/1 | Tablet, Film coatedOral | Camber Pharmaceuticals, Inc. | 31722-805 | 31722-0805-0131722-0805-0231722-0805-05+1 more |
| Tolterodine Tartrate | Tolterodine tartrate 2 mg/1 | Capsule, Extended releaseOral | Slate Run Pharmaceuticals, LLC | 70436-160 | 70436-0160-0270436-0160-0470436-0160-06 |
| Tolterodine Tartrate | Tolterodine tartrate 4 mg/1 | Capsule, Extended releaseOral | Slate Run Pharmaceuticals, LLC | 70436-161 | 70436-0161-0270436-0161-0470436-0161-06 |
| Tolterodine tartrate | Tolterodine tartrate 2 mg/1 | Tablet, Film coatedOral | Macleods Pharmaceuticals Limited | 33342-098 | 33342-0098-0933342-0098-1233342-0098-15 |
| Tolterodine tartrate | Tolterodine tartrate 1 mg/1 | Tablet, Film coatedOral | Macleods Pharmaceuticals Limited | 33342-097 | 33342-0097-0933342-0097-1233342-0097-15 |
Other NDCs under ANDA 203016
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Tolterodine Tartratetolterodine | Tolterodine tartrate 2 mg/1 | Capsule, Extended releaseOral | Torrent Pharmaceuticals Limited | 13668-189 |
| Tolterodine Tartratetolterodine | Tolterodine tartrate 4 mg/1 | Capsule, Extended releaseOral | Torrent Pharmaceuticals Limited | 13668-190 |
| Tolterodine Tartratetolterodine | Tolterodine tartrate 2 mg/1 | Capsule, Extended releaseOral | American Health Packaging | 60687-319 |